Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 30.42 · gapped above the open, then crossed back over prior close. High/low 30.91 at 10:00 am ET, 30.26 at 1:45 pm ET.
vTv Therapeutics Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
44 institutional managers report a position in vTv Therapeutics Inc. worth $60.5M between them, filed on form 13F for the quarter ending 2026-06-30. 7 of them hold 80% of it, the largest being Samsara BioCapital, LLC at 18.57%.
19 more managers in the register
7 managers hold 80% of the $60.5M institutional base. The other 37 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
VTVT (vTv Therapeutics Inc.) has 4 disclosed suppliers and 5 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: NVO +0.24%, in industrials & materials.
via Samsara BioCapital, LLC, Siren, L.L.C., Marshall Wace LLP · 18.57% of VTVT, 22.74% of RANI
via Samsara BioCapital, LLC, Siren, L.L.C., Marshall Wace LLP +1 more · 18.57% of VTVT, 71.42% of KLRS
via Samsara BioCapital, LLC, Baker Bros. Advisors LP, Trails Edge Capital Partners, LP +2 more · 18.57% of VTVT, 9.84% of NGNE
via Siren, L.L.C., Baker Bros. Advisors LP, HRT Financial LLC · 10.14% of VTVT, 8.63% of DBVT
via Baker Bros. Advisors LP, Trails Edge Capital Partners, LP, Marshall Wace LLP · 9.23% of VTVT, 9.14% of FTH
via Siren, L.L.C., Samsara BioCapital, LLC, Marshall Wace LLP · 10.14% of VTVT, 6.87% of SRRK
Managers holding a meaningful stake in VTVT also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.